Brain Cancer

New scan could predict response to brain cancer treatment

Published in Cancer Weekly, March 9th, 2004

A new type of brain scan could tell doctors whether or not a cancer treatment is working weeks earlier than is currently possible, researchers report.

Scientists found the technique - known as nuclear magnetic resonance (NMR) - was able to predict at an early stage how a brain tumor called a glioma was responding to treatment with the drug temozolomide.

The team of researchers, funded by Cancer Research U.K. and the Medical Research Council, at the Institute of Cancer Research, developed the scan from a machine widely used to identify molecules in chemistry laboratories. Their findings were published in the British Journal of Cancer.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-03-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry